IPS Features Q&A With Executive Director of Global HIV Vaccine Enterprise
April 27, 2010
In a Q&A with Inter Press Service, Executive Director of the Global HIV Vaccine Enterprise Alan Bernstein reflects on the recent progress made in HIV vaccine development and the need for partnerships between academia, industry, public and private funders to speed vaccine development. Bernstein also comments on how the global economy has impacted HIV vaccine research (Kharsany, 4/26).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.